Related Experiment Video
Updated: Oct 25, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Smoking cessation interventions in adults with attention deficit hyperactivity disorder (ADHD) or autism spectrum
Sarah Milne1, Nicola Blake1, Emma Jones2
1Public Health, East Sussex County Council, East Sussex, UK.
Objectives:
This is a protocol for a Cochrane review (intervention). The objectives are as follows: Primary objective To assess the effects of smoking cessation interventions, compared with no intervention, usual care, placebo, or alternative interventions, on sustained abstinence from smoking in adults with attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), or co-occurring ADHD and ASD. Secondary objectives To assess whether the effects of smoking cessation interventions differ between adults with ADHD, ASD, and co‑occurring ADHD and ASD. To assess whether intervention effects vary according to participant characteristics (e.g. ADHD or ASD symptom profiles, co‑occurring mental health conditions, and alcohol- or substance-use disorders). To assess the safety and acceptability of smoking cessation interventions, including serious and non-serious adverse events and treatment discontinuation.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Acute Coronary Syndrome IV: Interprofessional Care
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...